Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has issued an update.
ResMed Inc.’s Chief Financial Officer, Brett Sandercock, reported a change in beneficial ownership with the acquisition of 5,462 shares of ResMed common stock on August 15, 2025. This transaction reflects the vesting of performance-based restricted stock units, indicating the company’s achievement of certain performance metrics, which may positively impact stakeholder confidence and demonstrate strong company performance.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$51.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing on the development and manufacturing of cloud-connected devices and solutions for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. The company is known for its innovative products that improve quality of life and reduce the impact of chronic diseases.
Average Trading Volume: 890,958
Technical Sentiment Signal: Buy
Current Market Cap: A$64.61B
See more insights into RMD stock on TipRanks’ Stock Analysis page.